Summit Therapeutics SMMT
NASDAQ SMMT
$16.94 -0.89 (-4.96%)
As of: Nov 11, 2026 · 11:40 AM EST

Summit Therapeutics (SMMT) Net Long-Term Debt Issued (Repaid) (2021 - 2024)

Updated

Summit Therapeutics (SMMT) recorded Net Long-Term Debt Issued (Repaid) of -$75.5 million in Q4 2024.

Analysis

Summit Therapeutics (SMMT) Net Long-Term Debt Issued (Repaid) (2021 - 2024) Analysis & Trends

For FY2024, Summit Therapeutics reported Net Long-Term Debt Issued (Repaid) of -$100 million.

  • Across earlier years, Net Long-Term Debt Issued (Repaid) came in at -$24.69 million in FY2023 and $520 million in FY2022.
  • Quarterly Net Long-Term Debt Issued (Repaid) has ranged from -$75.5 million in Q3 2024 to $520 million in Q4 2022 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Summit Therapeutics 14.26 Bn 11.63 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -75.50 Mn
Sep 30, 2024 -75.50 Mn
Mar 31, 2023 -24.69 Mn
Dec 31, 2022 520.00 Mn
Sep 30, 2022 -25.00 Mn
Mar 31, 2022 25.00 Mn
Jun 30, 2021 55.00 Mn
Mar 31, 2021 55.00 Mn
API Access

Summit Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=SMMT&period=max&api_key=YOUR_API_KEY